| __timestamp | BioCryst Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 7461000 | 2999000 |
| Thursday, January 1, 2015 | 13047000 | 10393000 |
| Friday, January 1, 2016 | 11253000 | 15994000 |
| Sunday, January 1, 2017 | 13933000 | 26975000 |
| Monday, January 1, 2018 | 29514000 | 39509000 |
| Tuesday, January 1, 2019 | 37121000 | 48869000 |
| Wednesday, January 1, 2020 | 67929000 | 42510000 |
| Friday, January 1, 2021 | 118818000 | 46105000 |
| Saturday, January 1, 2022 | 159371000 | 50513000 |
| Sunday, January 1, 2023 | 213894000 | 51292000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational expenses is crucial for sustainability and growth. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Wave Life Sciences Ltd. and BioCryst Pharmaceuticals, Inc. over a decade, from 2014 to 2023.
BioCryst Pharmaceuticals has seen a staggering increase in SG&A expenses, rising from approximately $7.5 million in 2014 to over $213 million in 2023. This represents a growth of nearly 2,750%, indicating a significant expansion in their operational activities. In contrast, Wave Life Sciences Ltd. experienced a more moderate increase, with expenses growing from around $3 million to $51 million, a 1,600% rise.
This divergence in SG&A growth reflects differing strategic priorities and operational scales. Investors and stakeholders should consider these trends when evaluating the companies' financial health and strategic direction.
AbbVie Inc. vs Wave Life Sciences Ltd.: SG&A Expense Trends
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: SG&A Expense Trends
Selling, General, and Administrative Costs: Zoetis Inc. vs Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Wave Life Sciences Ltd.
Comparing SG&A Expenses: Bio-Techne Corporation vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and BioCryst Pharmaceuticals, Inc.
PTC Therapeutics, Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for Iovance Biotherapeutics, Inc. and Wave Life Sciences Ltd.